Vita C Plus Spot Correcting & Firming Cream

Vita C Plus Spot Correcting & Firming Cream

Marsoni

M251S

$24.95

Get it in 3 business days with 1 day shipping. Friday, May 29

Vita C Plus Spot Correcting & Firming CreamBeschreibung: Die Missha Vita C Plus Spot Correcting & Firming Cream ist eine mit Vitamin C und Kollagen angereicherte Gesichtscreme fr eine hellere, festere und strahlendere Haut. Sie glttet Fltchen, erhht die Elastizitt der Haut und gleicht Pigment und Altersflecken aus. So benutzt Du das Produkt: Verteile eine moderate Menge der Creme mit einem sauberen Spatel. Trage sie auf das gesamte Gesicht auf und massiere sie sanft ein, damit sie besser

Easy Shipping

Quick Dispatch:

Your Vita C Plus Spot Correcting & Firming Cream orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Vita C Plus Spot Correcting & Firming Cream ships.

Need Help?
Questions about Vita C Plus Spot Correcting & Firming Cream, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Vita C Plus Spot Correcting & Firming Cream in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

After a stressful day (aren't they all) I often have trouble getting to sleep. I keep these on my nightstand and take one before bed. I find it allows me to fall asleep easily and stay asleep all night. There is no problem with being groggy in the morning like other sleep aids. Ashwaganda is an adaptogen and is supposed to be helpful for other things too. Been using these for months!

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on September 9, 2025